Kanner A - Search Results

1

Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.

Cohen MJ, Meador KJ, Browning N, May R, Baker GA, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD study group. Cohen MJ, et al. Among authors: kanner a. Epilepsy Behav. 2013 Nov;29(2):308-15. doi: 10.1016/j.yebeh.2013.08.001. Epub 2013 Sep 5. Epilepsy Behav. 2013. PMID: 24012508 Free PMC article.

2

Postmarketing experience with topiramate and cognition.

Tatum WO 4th, French JA, Faught E, Morris GL 3rd, Liporace J, Kanner A, Goff SL, Winters L, Fix A; PADS Investigators. Post-marketing antiepileptic drug survey. Tatum WO 4th, et al. Among authors: kanner a. Epilepsia. 2001 Sep;42(9):1134-40. doi: 10.1046/j.1528-1157.2001.41700.x. Epilepsia. 2001. PMID: 11580760 Free article.

3

Cognitive and behavioral effects of antiepileptic drugs.

Meador KJ, Gilliam FG, Kanner AM, Pellock JM. Meador KJ, et al. Among authors: kanner am. Epilepsy Behav. 2001 Aug;2(4):SS1-SS17. doi: 10.1006/ebeh.2001.0235. Epilepsy Behav. 2001. PMID: 12609218 No abstract available.

4

The diagnostic significance of video-EEG monitoring findings on pseudoseizure patients differs between neurologists and psychiatrists.

Harden CL, Burgut FT, Kanner AM. Harden CL, et al. Epilepsia. 2003 Mar;44(3):453-6. doi: 10.1046/j.1528-1157.2003.33002.x. Epilepsia. 2003. PMID: 12614403 Free article.

5

A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events.

Kanner AM, Wuu J, Faught E, Tatum WO 4th, Fix A, French JA; PADS Investigators. Kanner AM, et al. Epilepsy Behav. 2003 Oct;4(5):548-52. doi: 10.1016/j.yebeh.2003.07.007. Epilepsy Behav. 2003. PMID: 14527497 Clinical Trial.

6

Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy.

Jones JE, Hermann BP, Barry JJ, Gilliam FG, Kanner AM, Meador KJ. Jones JE, et al. Epilepsy Behav. 2003 Oct;4 Suppl 3:S31-8. doi: 10.1016/j.yebeh.2003.08.019. Epilepsy Behav. 2003. PMID: 14592638 Review.

7

Screening for major depression in epilepsy with common self-report depression inventories.

Jones JE, Hermann BP, Woodard JL, Barry JJ, Gilliam F, Kanner AM, Meador KJ. Jones JE, et al. Epilepsia. 2005 May;46(5):731-5. doi: 10.1111/j.1528-1167.2005.49704.x. Epilepsia. 2005. PMID: 15857440 Free article.

8

Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation.

Jones JE, Hermann BP, Barry JJ, Gilliam F, Kanner AM, Meador KJ. Jones JE, et al. J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):172-9. doi: 10.1176/jnp.17.2.172. J Neuropsychiatry Clin Neurosci. 2005. PMID: 15939970 Clinical Trial.

9

Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.

Ficker DM, Privitera M, Krauss G, Kanner A, Moore JL, Glauser T. Ficker DM, et al. Among authors: kanner a. Neurology. 2005 Aug 23;65(4):593-5. doi: 10.1212/01.wnl.0000172932.95985.51. Neurology. 2005. PMID: 16116122 Clinical Trial.

10

Rapid detection of major depression in epilepsy: a multicentre study.

Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Gilliam FG, et al. Lancet Neurol. 2006 May;5(5):399-405. doi: 10.1016/S1474-4422(06)70415-X. Lancet Neurol. 2006. PMID: 16632310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

391 results

Search Page